The Grey Zones of Classic Hodgkin Lymphoma by Jan Bosch-Schips, Massimo Granai, Leticia Quintanilla-Martinez, Falko Fend

Subjects: “…classic Hodgkin lymphoma…”
Get full text

Controversies in the Treatment of Classical Hodgkin Lymphoma by Dennis A. Eichenauer, Marc André, Peter Johnson, Alexander Fossa, Olivier Casasnovas, Andreas Engert

“…Abstract. Hodgkin lymphoma (HL) is a B-cell-derived malignancy that mostly affects young adults. …”
Get full text

ANTICARDIOLIPINIC ANTIBODIES IN NON-HODGKIN LYMPHOMA by Sanda Buruiana, Minodora Mazur, Maria Robu, Victor Tomacinschii

“…Objective: Identification of hemostasis changes in patients with non-Hodgkin's lymphoma (NHL) and anticardiolipin antibodies (aCL). …”
Get full text

Fertility in female survivors of Hodgkin's lymphoma by Irene Biasoli, Simona Falorio, Stefano Luminari, Nelson Spector, Massimo Federico

Subjects: “…Hodgkin's lymphoma…”
Get full text

Pulmonary Hodgkin Lymphoma Misdiagnosed as Tuberculosis by Mahdia Gholamnejad, Nasim Valizadeh

Subjects: Get full text

Hodgkin Lymphoma: A Special Microenvironment by Giuseppina Opinto, Claudio Agostinelli, Sabino Ciavarella, Attilio Guarini, Eugenio Maiorano, Giuseppe Ingravallo

Get full text

Actinomycosis of the Tongue in Non-Hodgkin Lymphoma by Mustafa PEHLİVAN, Yavuz YENİÇERİOĞLU, Binnaz ŞEKEROĞLU, Hayri ÖZSAN, Fatih DEMİRKAN, Erdener ERDEN, Bülent ÜNDAR

Subjects: Get full text

DIAGNOSIS OF CHILDHOOD NON-HODGKIN LYMPHOMA by Adriana Sărsan, Constantin Arion

Subjects: “…childhood non-hodgkin lymphoma…”
Get full text

Prognostic factors in non-Hodgkin lymphomas by Karin Zattar Cecyn, José Salvador Rodrigues de Oliveira, Antônio Correia Alves, Maria Regina Regis Silva, José Kerbauy

Subjects: “…Non-Hodgkin lymphoma…”
Get full text

NFkB Pathway and Hodgkin Lymphoma by Fabrice Jardin

Subjects: “…Hodgkin lymphoma…”
Get full text

Brentuximab vedotin in pediatric Hodgkin lymphoma by Shuvadeep Ganguly, Sneh Bhargava, Ajay Gogia

Get full text

Immune Checkpoint Inhibition in Hodgkin Lymphoma by Ryan H. Moy, Anas Younes

“…Correspondingly, immune checkpoint inhibitors that block PD-1/PD-L1 signaling have shown marked therapeutic efficacy in certain cancers, such as Hodgkin lymphoma. Reed-Sternberg cells, the hallmark cells of Hodgkin lymphoma, commonly overexpress PD-1 ligands, and recent clinical trials have demonstrated impressive response rates with the PD-1 inhibitors nivolumab and pembrolizumab in relapsed or refractory Hodgkin lymphoma, leading to their FDA approval in this setting. …”
Get full text

Suicide in European Hodgkin Lymphoma Patients by Austin I. Kim, Helen Goergen, Andreas Engert, Ann S. LaCasce, Louise Maranda, Bruce Barton, Sven Borchmann

“…The purpose of this study was to determine whether there is an increased risk of suicide in European Hodgkin Lymphoma (HL) patients compared to the general European population. …”
Get full text

Frequency of Autoantibodies on Non-Hodgkin Lymphoma by Sonia Guadalupe Barreno-Rocha, Sandra Guzmán-Silahua, Ernesto Germán Cardona-Muñoz, Maria Guadalupe Zavala-Cerna, David Eduardo Muñoz Gaytan, Carlos Riebeling-Navarro, Benjamín Rubio-Jurado, Arnulfo Hernán Nava-Zavala

Subjects: Get full text

Immunotherapy in indolent Non-Hodgkin's Lymphoma by Ghid Amhaz, Ali Bazarbachi, Jean El-Cheikh

Subjects: “…Non-hodgkin lymphoma…”
Get full text

TREATMENT OF RELAPSE AND REFRACTORY HODGKIN LYMPHOMA by E. A. Baryakh

Subjects: “…hodgkin lymphoma…”
Get full text

AIDS-associated non-Hodgkin lymphoma. by Beral, V, Peterman, T, Berkelman, R, Jaffe, H

“…Non-Hodgkin lymphoma is associated with HIV infection. We investigated the epidemiology and aetiology of AIDS-related non-Hodgkin lymphoma by analysing data from cases reported to the Centers for Disease Control, Atlanta, USA, up to June 30, 1989. …”

Clinical association with non-hodgkin lymphoma by Abdullah, Wan Zaidah

“…Introduction: The association of anti phospholipid antibodies (APA) with Non..Hodgkin Lymphoma~) has been reported and complete remission was associated with disappearance of APA. …”
Get full text

Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas by Gascoyne Randy D, Skinnider Brian, Cohn Jason B, Fadlelmola Faisal M, Zhou Minglong, Banerjee Diponkar

“…A disease-specific protein marker is yet to be identified in Hodgkin lymphoma cells. In order to define HL-specific biomarkers, novel murine monoclonal antibodies were developed in our laboratory.…”
Get full text

P018 (0139) GATA3 EXPRESSION DISTINGUISHES CLASSIC HODGKIN LYMPHOMA FROM NODULAR LYMPHOCYTE HODGKIN LYMPHOMA

Get full text